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Abstract 
Technologies for multimodal digital imaging of vitreoretinal diseases have improved the accuracy of diagnosis 
and the depth of the knowledge of the mechanisms of disease and their response to treatments. Optic coherence 
tomography (OCT) has become a mandatory tool for the management and for the follow-up of retinal pathologies. 
OCT technology evolved in the last two decades from time-domain to spectral domain and recently to the swept-
source OCTs (SS-OCT). SS-OCT improved the depth of imaging and the scan speed, thus adding novel algorithms 
and features such as for vitreous and vitreoretinal interface evaluation, choroid segmentation and mapping, OCT 
angiography and En-face OCT. The multimodal approach using SS-OCT is expected to advance the understanding of 
retinal pathologies such as age related macular degeneration, diabetic maculopathy, central serous chorioretinopathy, 
the pachychoroid spectrum and macular telangiectasia. Surgical vitreoretinal diseases such as vitreo-macular trac-
tion syndrome, epiretinal membrane, retinal detachment, proliferative vitreoretinal retinopathy and diabetic traction 
retinal detachment also will be better understood and documented with SS-OCT. This technology also provides great 
utility for a broad spectrum of ophthalmic pathologies including glaucoma, uveitis, tumors and anterior segment 
evaluation.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Optic coherence tomography (OCT) is a technology 
introduced by Huang and associates [1] that became the 
prevailing technology for noninvasive assessment of the 
anterior and posterior segments.
The OCT is an imagining modality that enables the 
documentation of tissue structure or pathologies in 
real time and in  situ with a resolution from 1 to 15 µm 
[2]. The eye is the most optically accessible organ of the 
human body, both anterior and posterior segments can 
be documented [3]. OCT can be used to measure differ-
ent structures of the retina and is useful for the diagnosis 
and for the detection of progression of conditions such as 
macular edema and glaucoma [4, 5].
Time-domain OCT (TD-OCT) uses low-coherence 
light that split into two beams at a partially reflect-
ing mirror, one is aimed at the tissue and the other at 
the moving reference arm. The beams then recombine 
at a photodetector and the interference is assessed to 
determine the measurement of the tissues [2]. Spectral-
domain OCT (SD-OCT) was first demonstrated in 2002 
[6, 7]. SD-OCT improved image resolution and scan 
speed [8]. Speed ranging from 29,000 to 80,000 scans per 
second and an axial resolution up to 2 µm were demon-
strated [9, 10]. The increased number of images acquired 
improves the area of the retina evaluated, as well as the 
visualization of retinal structures. The higher speed of 
the SD-OCT acquisition enables it to obtain tridimen-
sional volumetric data to show scans perpendicular to 
the scanning axis: C-scans. [11].
Other features present in some commercially available 
SD-OCTs are the ART (automatic real time) mode that 
improves the resolution with noise reduction and the 
eye-tracking that follows the saccadic movements and 
can be used in combination with the ART mode [12]. 
The enhanced depth imaging (EDI) mode was developed 
to improve the visualization of deep structures such as 
external retina, retinal pigmentary epithelium (RPE), 
choroid and sclera [13] (Fig. 1).
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The recently introduced SS-OCT uses a short cav-
ity swept laser with a tunable wavelength of operation 
instead of the diode laser used in spectral-domain OCT 
[14]. The SS-OCT has improved image penetration using 
a wavelength of 1050 nm and has an axial resolution of 
5.3 µm and a axial scan rate of 100.000 scans per second. 
Prototype models could reach faster scan-speeds of more 
than 400.000 scans per second [15, 16]. The 12 × 9 mm 
scan enables simultaneous imaging of the macula, the 
peripapillary area and the optic nerve head and the 
choroidal thickness. The 12  ×  9  mm scan comprises 
256 B-scans each comprising 512 A-scans with a total 
acquisition time of 1.3 s [17]. SS-OCT also provides the 
capability of a wide field up to 12 × 12 mm images [18]. 
SS-OCT enables clear simultaneous visualization of the 
vitreous and the posterior pre-cortical vitreous pockets 
and the choroid and the sclera [19].
The present review highlights some important 
advances in retinal diagnosis provided by SS-OCT. The 
SS-OCT commercially available in several countries, 
including Brazil, is the Tritontm SS-OCT (Topcon, Tokyo, 
Japan). Its central wavelength is 1050 × nm and the speed 
scan is 100,000 A-scans per second.
There are other SS-OCTs that are still prototypes and 
to this date are not commercially available such as the 
Plex Elite Zeiss 9000, the vertical cavity surface emitting 
laser (VCSEL) OCT angiography from Massachusetts 
Institute of Technology (MIT) and a swept source mega-
hertz OCT that operates with a 1050 nm wavelength and 
reaches scan speeds of 1.68 MHz [16]. The VCSEL ultra-
high speed prototype operates at 1060  nm wavelength 
which allows increased light penetration into pigmented 
tissues and improved choroidal blood flow visualization. 
It obtains 500 × 500 A-scans at 400,000 A-scans per sec-
ond in approximately 3.8 s. This ultra-high speed allows 
wider fields of view up to 12 × 12 mm. [18].
The scope of this review will include vitreous evalua-
tion using the Enhanced Vitreous Visualizationtm (EVV), 
the choroid evaluation, En-face SS-OCT and OCT 
angiography (OCTA) and selected features of the SS-
OCT utility in age-related macular degeneration (AMD), 
in central serous chorioretinopathy (CSCR), in diabetic 
maculopathy and in macular telangiectasia (Mactel).
Vitreous structures imaging
The vitreous is a transparent hydrophilic gel, mainly com-
posed of water, occupying the space between the lens and 
the retina and functions as a pathway for nutrients uti-
lized by the lens, ciliary body and retina [20]. The advent 
of the spectral-domain OCT (SD-OCT) allowed better 
visualization of the vitreoretinal interface and posterior 
vitreous cortex and is widely used in the diagnosis and 
management of many diseases including: vitreomacualar 
traction (VMT), epiretinal membrane (ERM) [21], lamel-
lar holes, pseudoholes and full thickness macular holes 
[20, 22]. However, swept-source OCT (SS-OCT) has ena-
bled higher speed, longer imaging range and lower sen-
sitivity roll-off compared with SD-OCT. SS-OCT uses a 
longer wave length and has less variation in sensitivity 
with depth (roll-off) compared with SD-OCT [15].
SS-OCT has also the enhanced vitreous imaging where 
the image can be seen in different logarithmic scales, or 
windows, for better visualization of the vitreous struc-
tures [19, 23]. Another complementary approach is to 
use equalization algorithms to convert the high-dynamic 
range (HDR) images to a displayable range while preserv-
ing contrast, brightness and other fine details [24]. The 
Triton tm SS-OCT (Topcon, Tokyo, Japan) uses a feature 
called EVV (Enhanced Vitreous Visualizationtm) where 
these different windows for vitreous visualization can be 
appreciated (Fig. 2). Structures such as bursa premacula-
ris, or the posterior precortical vitreous pockets (PPVP), 
the Maregiani area (Clocquet’s canal), posterior cortical 
vitreous, posterior hyaloid and vitreous opacities of dif-
ferent etiologies are more properly viewed with SS-OCT 
[20, 25].
The presence of PPVP has a key role in various vitre-
omacular disorders [26, 27]. The PPVP was recently 
Fig. 1 Spectral domain OCT with enhanced depth imaging (EDI) mode
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visualized during vitrectomy using intravitreal injection 
of triamcinolone acetonide [28]. SD-OCT first allowed 
in  vivo, non-invasive, observation of the PPVP [29]. It 
was reported that perifoveal vitreous detachment is the 
primary pathogenic event in idiopathic macular hole for-
mation [30, 31]. In myopic eyes, SS-OCT clearly showed 
the PPVP increased area [19]. Retinoschisis at the fovea is 
a common feature in eyes with posterior staphyloma and 
it appears to be a consequence of vitreoretinal tractions 
[32, 33]. The SS-OCT was also reported to detect periph-
eral lesions using a wide field of view that included reti-
noschisis, diabetic retinopathy, choroidal melanoma and 
choroidal nevi [34].
Other vitreoretinal interface diseases such as epiretinal 
membrane and macular pucker, vitreomacular traction 
syndrome and tractional retinal detachment in prolifera-
tive diabetic retinopathy, that are well described with SD-
OCT, may also be documented with higher resolution 
and on broader scans with SS-OCT.
Choroidal imaging and quantitative evaluation
The choroid receives approximately 70  % of the blood 
flow in the eye; it has the highest blood flow per unit 
weight of any tissue in the body, about 20–30 times 
greater than that of the retina [35–37]. Choroid supplies 
oxygen and metabolites to the outer retina, retinal pig-
ment epithelium (RPE), the avascular fovea and possibly 
the prelaminar portion of the optic nerve [38] and serves 
as a heat sink [39]. The ophthalmic artery, branches to 
form the central retinal artery and the posterior ciliary 
arteries (PCAs), the PCAs divide in braches which the 
two major ones (anterior PCAs) supply the anterior uvea 
and the smaller short PCAs, usually 20 in number, enter 
the eye, particularly around the optic nerve and macular 
region [40]. Venous drainage from the choriocapillaris is 
mainly through the vortex veins and a minor system of 
anterior ciliary veins through the ciliary body [35].
The anatomy of the choroid is traditionally described 
in layers: outer large vessels containing Haller layer, the 
middle vessels containing Sattler layer and the inner cho-
riocapillaris [35, 41]. The vitality of the choriocapillaris, 
including the presence of fenestrations, is maintained 
in part by consecutive secretion of vascular endothelial 
growth factor (VEGF) by the RPE [42].
OCT techniques that better visualize the choroid is 
the EDI of the SD-OCT, imaging averaging and SS-OCT. 
In SD-OCT, depth information is encoded as different 
frequencies of the interference spectrum, with increas-
ing depth into tissue, echoes beyond the point of detec-
tion are known as the “zero delay line.” Spectral domain 
Fig. 2 Swept source-OCT high resolution single scan using Enhanced Vitreous Visualizationtm (EVV) shows different windows for vitreous visualiza-
tion, from EVV 0 (a), 1 (b), 3 (c) and 5 (d)
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detection cannot distinguish between positive and nega-
tive echo delays, if a retinal structure crosses beyond the 
zero delay line, it will appear, as a mirror-like image with 
reversed depth sensitivity. This feature is used to enhance 
choroidal imaging. This technique was first reported by 
Spaide and associates as enhanced depth imaging (EDI). 
EDI is an acquisition software that automatically captures 
the cross-sectional image with the choroid close to the 
zero delay line to maximize the sensitivity on the outer 
limit of the choroid [43, 44].
The SS-OCT has a longer wavelength capable of pen-
etrating tissue more than the SD-OCT, thus both vitre-
ous and choroid can be imaged simultaneously. The first 
study to measure choroidal thickness (CT) by Margo-
lis and Spaide investigated 54 normal, non-myopic eyes 
with the EDI of the SD-OCT and found a sub-foveal 
thickness of 287 µm [45]. Regatieri and associates stud-
ied the different layers of the choroid and found a mean 
CT of 256.8 ± 75.8 μm, mean thickness of the large cho-
roidal vessel layer was 204.3 ± 65.9 μm, and that of the 
medium choroidal vessel layer–choriocapillaris layer was 
52.9 ± 20.6 μm beneath the fovea [46]. The CT seems to 
decrease with age, however there are patients that pre-
sent a pronounced loss of CT over time, a new condition 
named age-related choroidal atrophy [47].
Evaluation of CT is an important diagnostic hallmark 
of several retinal diseases. Choroidal hyperpermeability 
is the main feature in CSC [48], CT is increased in those 
patients [49, 50]. Wood and associates analyzed macu-
lar CT with SS-OCT in early AMD in different portions 
of the posterior pole and there was no significant dif-
ference from controls. Switzer and associates found that 
AMD features were associated with CT thinning [51]. 
The CT was greater in patients with polypoidal choroi-
dal vasculopathy (PCV) [52, 53]. CT was found impor-
tant to evaluate in inflammatory diseases involving 
the posterior segment: Vogh–Koyanagi–Harada [54], 
multifocal choroiditis and panuveitis, birdshot choroi-
doretinopathy, posterior scleritis, serpiginous choroi-
dopathy, sarcoidosis and infectious etiologies such as 
toxoplasmic retinochoroiditis. Choroidal evaluation, 
both quantitative and morphological may have utility 
in high myopia, tumors, retina dystrophies and in glau-
coma evaluation [43, 55].
CT may also play a role in diabetic retinopathy. Rega-
tieri and associates evaluated 49 eyes of type 2 diabetic 
retinopathy patients with SD-OCT, the sub-foveal CT 
was thinner in eyes with diabetic macular edema, or 
eyes with proliferative retinopathy and previous pan-
photocoagulation [56]. A study comparing CT in patients 
with microalbuminuria and in controls showed a signifi-
cant thinning in the second group (284.03  ±  12.56 vs. 
228.87 ± 14.44 μm; P = 0.001; 95 % CI 21.88–88.44) [57].
There have been several reports of foveal CT evalua-
tion, using SS-OCT [58]. Tan and associates compared 
the SD-OCT and SS-OCT CT measurements where dif-
ferences by more than 50  μm (SD-OCT thicker) were 
found [59]. Adhi and associates compared the CT meas-
ured with a prototype SS-OCD with a commercially 
available SD-OCT with and without EDI, there was no 
significant difference in the measurements on line scans 
obtained with both systems [60]. In other study, Adhi 
and associates used the prototype SS-OCT to evalu-
ate the different choroidal layers, as well as the total CT 
379.4 μm (SD ± 75.7 μm), the choriocapillaris and small 
vessels was 81.3  μm (SD ±  21.2  μm) and the choroidal 
large vessels layer was 298.1  μm (SD  ±  63.7  μm) [61]. 
The commercially available SS-OCT Tritontm (Topcon, 
Tokyo, Japan) measures the CT with automated segmen-
tation using a viewer software where each sector can be 
measured separately (Fig.  3). This feature has a promis-
ing role on the sectoral analysis and follow-up of retinal 
pathologies involving the choroid [62].
OCT angiography and en face OCT
SS-OCT uses a wavelength-tunable laser and a dual-bal-
anced photo detector instead of a broadband super-lumi-
nescent diode, spectrometer and high-speed line-scan 
camera that are used in SD-OCT. SS-OCT offers higher 
imaging speeds, higher detection efficiencies, improved 
imaging range and improved depth with reduced sensi-
tivity roll-off. Those features are a fundamental advan-
tage in comparison with SD-OCT and contributed to the 
improved image quality, including of the choroid, using 
SS-OCT [63, 64]. These advantages of SS-OCT make it a 
very useful diagnostic tool to preform En face OCT and 
OCTA.
Fluorescein (FA) and indocyanine green (ICGA) angi-
ographies are the gold standard for imaging the retinal 
vasculature, they are dynamic and provide the evaluation 
of the transit of the dye as well as the well-known diag-
nostic hallmarks of leakage and pooling of dye [65, 66]. 
However, with these modalities small retinal vessels and 
feeder vessels are often obscured by subsequent hyper-
fluorescence, and they involve the use of intravenous 
contrast that can result in serious systemic side effects 
[67].
OCTA is a noninvasive technology that uses the decor-
relation motion contrast between rapidly repeated OCT 
B-scans to visualize blood flow to document the retinal 
vasculature [68, 69]. OCTA images retinal vessels by 
detecting variations in the intensity and/or phase prop-
erties of the OCT signal over multiple B-scans resulting 
from the movement of red blood cells [70]. However, 
there are limitations such as signal attenuation from the 
RPE, media opacity, and retinal hemorrhage avoiding 
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the full visualization of sub-RPE lesions such as type 1 
choroidal neovascularization (CNV). This limitation has 
been previously reported in SD-OCT and can be over-
come with SS-OCT [71, 72] (Fig. 4). OCTA can also miss 
areas of slow blood flow. It relies on change between con-
secutive B-scans detecting flow only above a minimum 
threshold [18].
Novais and associates showed that En face OCTA 
images from a 1050-nm-wavelength ultrahigh-speed SS-
OCT provided a more accurate representation of CNV 
lesions compared to 840  nm-wavelength SD-OCT [73]. 
Roisman and associates showed that SS-OCT angiog-
raphy could identify type 1 neovascularization corre-
sponding to ICGA plaques in asymptomatic eyes with 
intermediate AMD [74].
The SS-OCT angiography has great potential both 
for the diagnosis of the three types of CNV and for the 
follow-up of the anti-vascular endothelial growth factor 
(anti-VEGF) treatment outcomes [75–77]. The En face 
SS-OCT may also add useful information for the diagno-
sis of CNV. Flores-Moreno and associates described that 
this modality could demonstrate changes in all patients 
with CNV at different levels of C-scans [78].
En face SS-OCT images are useful to diagnose patho-
logical features of CSC (Fig.  5). Ferrara and associates 
showed that at the RPE level there were specific changes 
in all eyes, which correlated with pathologic changes seen 
on cross-sectional SS-OCT and other imaging modali-
ties, including fundus auto-fluorescence and angiogra-
phy. They found in all eyes RPE detachment or loss with 
correspondent absence of SS-OCT signal at the RPE 
level. The neurosensory detachment areas showed heter-
ogeneous optically dense dots corresponding to RPE and 
photoreceptors debris [63]. Bonini Filho and associates 
demonstrated that OCTA had a sensitivity and specific-
ity comparable with FA to detect CNV in eyes with CSC 
[79]. The evaluation of the choroid with En face SS-OCT 
at the level of Sattler’s layer revealed dilation of medium-
sized choroidal vessels in two patterns: homogeneous 
and diffuse dilation of the vessels. The SS-OCT En face 
images of Haller’s layer revealed diffuse choroidal dila-
tion in the majority of the eyes (80 %) [63].
The evaluation of the choroid with SS-OCT En Face 
and OCTA may help to understand the pachychoroid 
spectrum disorders. Densingani and associates evaluated 
66 eyes with pachychoroid spectrum and found dilated 
choroidal vessels in all eyes. Other findings associated 
with chronic disease: focal choriocapillaris atrophy with 
inward displacement of deep choroidal vessels, were also 
appreciated [80].
Fig. 3 Swept source-OCT single scan shows automatic segmentation layers (a) with ETDRS thickness maps (b), 3D reconstruction (c) and point-by-
point automatic measurement of choroidal thickness (d)
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Another pathology involving the choroid that is better 
diagnosed with SS-OCT is the polypoidal choroidal vas-
culopathy (PCV). The diagnosis of PCV has been made 
based on clinical examination (subretinal orange nodules, 
haemorrhagic pigment epithelial detachment) and ICGA 
[81, 82]. OCT has also been described as a useful tool and 
its features are: “double layer sign” in branching vascular 
network; notched pigment epithelial detachment (PED) 
representing the polyp adherent to the undersurface of 
RPE within a PED; and the polyp itself that looks like a 
round hyporreflective lumem with a hyperreflective wall 
adjacent to it [83–85]. SS-OCT is superior in detecting 
the choroidal-scleral interface and IS/OS lines simultane-
ously [86]. The use of En face SS-OCT has showed rela-
tionship between larger PEDs and small adjoining PEDs 
that correlated with the polypoidal lesions seen on ICGA 
Fig. 4 OCT angiography of a patient with exudative age related macular degeneration after treatment with anti-VEGF, however it is still possible to 
identify choroidal neovascularization bellow the RPE with no signs of inner or subretinal fluid
Fig. 5 Enface OCT image of a patient with chronic central serous chorioretinopathy at the level of the RPE showing several hypereflective dots 
under the subretinal fluid and a larger hypereflective spot corresponding to the leaking point on fluorescein angiography
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[87]. OCTA also improved the multimodal diagnosis of 
PCV, showing the branching vascular network as well as 
a round structure with variable reflectivity [88].
The depth of the C-scan is an essential element of the 
usefulness of the OCTA. The possibility to evaluate dif-
ferent levels such as the superficial vascular plexus, the 
deep vascular plexus, the choroiocapillaris and the cho-
roidal vessels enhances the comprehension of the dif-
ferent retinal pathologies. The SS-OCT angiography 
improved the multimodal diagnosis of vascular patholo-
gies of the retina such as macular telangiectasia, dia-
betic maculopathy, proliferative diabetic retinopathy and 
occlusive vascular diseases (venous and arterial).
Macular telangiectasia type 2 (MacTel2) is a disease 
of the central macula that affects all microvascular lay-
ers of the retina and includes neovascularization aris-
ing from both the retinal and choroidal circulations. The 
early changes of MacTel2 are in the temporal aspect of 
the deep vessels, then into microvasculature around the 
fovea in superficial vessels and into anastomoses between 
the deep and the superficial plexus. In some patients, the 
anastomoses progress to form sub-retinal neovasculari-
zation. OCTA reveals these changes at every stage of dis-
ease progression [89–91] (Fig. 6).
Diabetic maculopathy and proliferative diabetic retin-
opathy tomographic features can be appreciated with 
detail using SS-OCT, En face SS-OCT and OCTA 
(Fig.  7). Studies demonstrated that OCTA was able to 
determine relevant vascular changes in subjects with dia-
betic retinopathy, including microaneurysms, impaired 
vascular perfusion, some forms of intra-retinal fluid, vas-
cular loops, intra-retinal microvascular abnormalities, 
neovascularization, and cotton-wool spots. Those find-
ings were largely consistent with FA [92, 93]. Compared 
with FA, it identified fewer microaneurysms, but located 
their exact intraretinal depth. OCTA also allowed the 
precise and reproducible delineation of the foveal non-
flow zone [93].
Fig. 6 Swept source-OCT high resolution single scan of a patient with macular telangiectasia type 2 with corresponding fundus imaging (a), and 
OCT angiography (b) of same patient that shows vascular tortuosity and dilation in superficial and deep layers with no signs of vascular changes on 
outer retina or choriocapillaris
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The abnormalities in perfusion seen both in diabetic 
retinopathy and in retinal vein or artery occlusion are 
well documented with OCTA. Density maps determin-
ing quantitatively this feature were described and have a 
potential to be an additional tool for the diagnosis or reti-
nal vascular disease. The SS-OCT angiography prototype 
using variable inter-scan time analysis (VISTA) using a 
1050-nm wavelength, 400-kHz A-scan rate is a promis-
ing tool to quantitatively determine flow and to assess its 
impairments in different retinal pathologies [94]. The use 
of OCTA in retina vein occlusion (RVO) was reported 
and showed the precise identification of the retinal vas-
culature as well as the areas of non-perfusion at multiple 
retinal levels. The limitations of OCTA are a smaller field 
of view than FA and the absence of dynamic (transit time, 
speed of flow) and of vascular leakage information [95].
Summary
The SS-OCT has increased scan speed and a deeper pen-
etration than previous modalities of OCT. The deeper 
penetration allows the simultaneous detailed documen-
tation of the vitreous and the choroid. It visualizes bet-
ter the choroidal structures and also sub-RPE pathology 
such as type 1 CNV. The commercially available SS-OCT 
has different windows for better vitreous visualization 
(Enhanced Vitreous Viewtm) as well as segmentation and 
mapping of choroidal thickness. The En Face OCT and 
the SS-OCT angiography have improved the diagnosis 
and the understanding of the features of retinal patholo-
gies including: CNV of different types and etiologies 
including AMD, CSC and the pachychoroid spectrum, 
PVC, MacTel, diabetic retinopathy and retinal vascular 
occlusions. The quantitative evaluation of flow param-
eters in different pathologies will add important informa-
tion, especially the ones with vascular etiology.
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